STAAR Surgical Company (NASDAQ:STAA) Q1 2024 Earnings Call Transcript
STAAR Surgical Company misses on earnings expectations. Reported EPS is $-0.06827 EPS, expectations were $0.05.
Staar Surgical Co (STAA)
Market is closed
Sector: Ophthalmic Goods
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Broadwood Capital Neal C. Bradsher | 10,768,430 | $412,215,500 | +3% | 30.97% |
| 2. | Palo Alto Investors William Leland Edwards | 1,379,590 | $52,810,705 | +1% | 5.95% |
| 3. | Yunqi Capital Christopher Wang | 515,300 | $19,725,684 | +162% | 13.63% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 207,997 | $7,962,124 | +27% | 0.01% |
| 5. | Citadel Investment Group Ken Griffin | 203,818 | $7,802,153 | -51% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | Large Shareholder | 10,768,431 | 2024-05-09 | Filing | |
| $42.56 | 1 | Large Shareholder | 10,768,431 | 2024-05-09 | Filing | |
| $38.11 | 1,750 | 10,864 | 2024-03-14 | Filing | ||
| $0.00 | 0 | Large Shareholder | 10,768,430 | 2024-01-08 | Filing | |
| $27.11 | 4,042 | Large Shareholder | 10,768,430 | 2024-01-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $61.97 | 823 | Officer | 27,633 | 2023-03-17 | Filing | |
| $75.00 | 13,075 | Officer | 34,908 | 2022-09-27 | Filing | |
| $75.00 | 15,683 | Officer | 34,908 | 2022-09-27 | Filing | |
| $75.00 | 6,667 | Officer | 50,591 | 2022-09-27 | Filing | |
| $106.22 | 5,000 | Officer | 19,437 | 2022-08-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,159,763 | $254,666,204 | 0% | |
| 2. | 5,468,710 | $170,678,439 | 0% | |
| 3. | 4,448,208 | $138,828,572 | 0.11% | |
| 4. | 1,934,438 | $60,373,810 | 0% | |
| 5. | 1,694,992 | $52,900,700 | 1.71% |
News See All
STAAR Surgical Company (NASDAQ:STAA) Q4 2023 Earnings Call Transcript
STAAR Surgical Company beats earnings expectations. Reported EPS is $0.24, expectations were $0.19.
STAAR Surgical Company (NASDAQ:STAA) Q3 2023 Earnings Call Transcript
Operator: Good day ladies and gentlemen. Thank you for standing by. Welcome to the STAAR Surgical Third Quarter Financial Results Conference Call.
STAAR Surgical Company (NASDAQ:STAA) Q2 2023 Earnings Call Transcript
Operator: Good day ladies and gentlemen. Thank you for standing by. Welcome to the STAAR Surgical Second Quarter Financial Results Conference Call.
STAAR Surgical Company (NASDAQ:STAA) Q1 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to the STAAR Surgical First Quarter Financial Results Conference Call.
STAAR Surgical Company (NASDAQ:STAA) Q4 2022 Earnings Call Transcript
Operator: Good day ladies and gentlemen. Thank you for standing by. Welcome to the STAAR Surgical Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call.
15 Largest Ophthalmology Companies in the World
In this article, we will take a look at the 15 largest ophthalmology companies in the world.
Where Do Hedge Funds Stand On STAAR Surgical Company (STAA)?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
5 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors
In this article, we will discuss 5 biotech and pharmaceutical stocks to buy according to Palo Alto Investors based on Q2 holdings of the fund.
Hedge Funds Are Piling Into STAAR Surgical Company (STAA)
A whopping number of 13F filings filed with U.S.
Billionaire Hedge Funds
